Pacer Advisors »

Nurix Therapeutics shares owned by Pacer Advisors

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $15k 985 14.70
2021-03-31 $49k 1.6k 30.99
2020-12-31 $18k 539 33.40

More positions owned by Pacer Advisors

Exxon Mobil Corp Common Stock - Domestic (XOM)
3M Common Stock - Domestic (MMM)
Valero Energy Corp Common Stock - Domestic (VLO)
Vistra Corp Common Stock - Domestic (VST)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Marathon Petroleum Corp Common Stock - Domestic (MPC)
Chevron Corp Common Stock - Domestic (CVX)
Altria Group Common Stock - Domestic (MO)
EOG Resources Common Stock - Domestic (EOG)
CVS Health Corp Common Stock - Domestic (CVS)
At&t Common Stock - Domestic (T)
United States Treasury Bill Treasury Bill (Principal)
Cisco Systems Common Stock - Domestic (CSCO)
Gilead Sciences Common Stock - Domestic (GILD)
Diamondback Energy Common Stock - Domestic (FANG)

View all positions for Pacer Advisors

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
ARK Investment Management
Vanguard Group
Morgan Stanley
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Bain Capital Life Sciences Investors
Soleus Capital Management
Geode Capital Management
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics